Loading data for AVTX — first visit, this takes a few seconds.
Avalo Therapeutics Inc. (AVTX)
NasdaqCM: AVTX
· Real-Time Price · USD
19.27
-0.56 (-2.82%)
At close: Aug 24, 2026, 8:00 PM
The price, the headline numbers and the latest news, in one place.
Avalo Therapeutics Inc. (AVTX) Stock Price, Analysis & Data
-2.82% (1D)
No data available
| Bid | 13.99 |
| Market Cap | 1.03B |
| Revenue (ttm) | n/a |
| Net Income (ttm) | n/a |
| n/a | |
| n/a | |
| n/a | |
| -7.32 | |
| P/B (ttm) | 2.27 |
| P/S (ttm) | n/a |
| Earnings Date | Nov 12, 2026 |
| Ask | 24.88 |
| Volume | 759,038 |
| Avg. Volume (20D) | |
| Open | 19.86 |
| Previous Close | 19.83 |
| Day's Range | 18.88 - 19.86 |
| 52-Week Range | 8.65 - 24.27 |
| Analyst | n/a |
| Price Target | n/a |
| Dividends | n/a |
| Ex-Dividend Date | n/a |
About AVTX
A detailed description of the company is not yet available....
Industry n/a
Sector n/a
IPO Date Oct 14, 2015
Employees n/a
Stock Exchange NasdaqCM
Ticker Symbol AVTX
Financial Performance
In 2025, Avalo Therapeutics's revenue was 59K, a decrease of -86.62% compared to the previous year's 441K. Earnings were -78.26M, an increase of 122.78%.
Financial StatementsEarnings Surprise
Avalo Therapeutics has released their quarterly earnings on Aug 6, 2026:
- Revenue of $0 misses estimates by $0, with NaN% YoY growth.
- EPS of -0.83 misses estimates by -0.21, with 56.77% YoY growth.
Avalo Therapeutics Inc. is scheduled to release its earnings on Nov 12, 2026, before market opens.
Analysts project revenue of ... Upgrade
Analysts project revenue of ... Upgrade
Page 1 of 2